Table 3.
Univariate and Multivariate Analyses for OS
Definitive CCRT | Adjuvant CCRT | ||||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | |||||||
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
Age, ≥65 | 0.85 | 0.37–1.94 | 0.69 | 0.89 | 0.38–2.11 | 0.80 | 0.26 | 0.07–0.95 | 0.04 |
Sex, Male | 1.56 | 0.54–4.52 | 0.41 | 2.10 | 0.68–6.41 | 0.19 | 1.45 | 0.19–11.0 | 0.71 |
PS, ≥1 | 2.56 | 1.04–6.40 | 0.04 | 1.23 | 0.47–3.20 | 0.66 | 0.68 | 0.19–2.39 | 0.54 |
Smoking, Current/former | 0.67 | 0.28–1.60 | 0.37 | 1.03 | 0.29–3.62 | 0.96 | |||
Primarysite, Naso/oropharynx | 0.58 | 0.26–01.28 | 0.18 | 0.82 | 0.18–3.01 | 0.79 | |||
Stage, IV | 3.99 | 1.83–8.73 | <0.01 | 2.64 | 1.15–6.07 | 0.02 | 3.77 | 0.85–16.6 | 0.07 |
Baseline albumin, <4 | 4.01 | 1.88–8.56 | <0.01 | 3.91 | 1.78–8.59 | <0.01 | 0.62 | 0.22–1.72 | 0.36 |
Cachexia | 5.81 | 2.72–12.41 | <0.01 | 4.31 | 1.93–9.61 | <0.01 | 0.64 | 0.20–2.01 | 0.45 |
Abbreviations: PS, performance status; CCRT, concurrent chemoradiotherapy.